目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Technology
1.1.3 Application
1.1.4 Test Location
1.1.5 Regional Scope
1.1.6 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Insights
2.3 Competitive Insights

Chapter 3 IVD Infectious Disease Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.3.3 List of key end users
3.4 Regulatory Framework
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Growing geriatric population
3.5.1.2 Technological advancements
3.5.1.3 High demand for PoC facilities
3.5.1.4 Increasing prevalence of infectious diseases
3.5.1.5 External funding for R&D activities
3.5.2 Market restraint analysis
3.5.2.1 High prices of IVD tests
3.5.3 Industry challenges
3.5.3.1 Presence of ambiguous regulatory framework
3.6 IVD Infectious Disease Market Analysis Tools
3.6.1 Industry Analysis - Porter’s Five Forces
3.6.2 PESTLE Analysis
3.6.3 Major deals and strategic alliances analysis
3.6.3.1 New product launch
3.6.3.2 Mergers and acquisitions
3.6.3.3 Expansion
3.6.3.4 Partnerships
3.6.3.5 Marketing & promotions
3.6.4 Market entry strategies

Chapter 4 IVD Infectious Diseases Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Product Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global IVD Infectious Diseases Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Software
4.5.3.1 Software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 IVD Infectious Diseases Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Technology Type Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global IVD Infectious Diseases Market, by Technology, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Immunoassay
5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Molecular Diagnostics
5.5.2.1 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.3 Polymerase Chain Reaction (PCR)
5.5.2.3.1 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.4 In Situ Hybridization
5.5.2.4.1 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.5.2.5.1 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.6 Chips and Microarrays
5.5.2.6.1 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.7 Sequencing & NGS
5.5.2.7.1 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.8 Transcription Mediated Amplification
5.5.2.8.1 Transcription mediated amplification market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.9 Others
5.5.2.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Microbiology
5.5.3.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 IVD Infectious Diseases Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Application Type Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global IVD Infectious Diseases Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 MRSA
6.5.1.1 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Streptococcus
6.5.2.1 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3 Clostridium Difficile
6.5.3.1 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4 Vancomycin-resistant Enterococci (VRE)
6.5.4.1 VRE market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5 Carbapenem-resistant Enterobacterial Testing (CRE)
6.5.5.1 CRE market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6 Respiratory Virus
6.5.6.1 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7 Candida
6.5.7.1 Candida market estimates and forecast, 2018 - 2030 (USD Million)
6.5.8 Tuberculosis (TB) & Drug-resistant TB
6.5.8.1 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
6.5.9 Gastrointestinal (GI) Panel Testing
6.5.9.1 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
6.5.10 Chlamydia
6.5.10.1 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.11 Gonorrhea
6.5.11.1 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
6.5.12 Human papillomavirus (HPV)
6.5.12.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
6.5.13 Human immunodeficiency virus (HIV)
6.5.13.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
6.5.14 Hepatitis C
6.5.14.1 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
6.5.15 Hepatitis B
6.5.15.1 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
6.5.16 COVID-19
6.5.16.1 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
6.5.17 Others
6.5.17.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 IVD Infectious Diseases Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 Test Location Type Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global IVD Infectious Diseases Market, by Test Location, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Point of Care
7.5.1.1 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Central Laboratories
7.5.2.1 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Others
7.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 IVD Infectious Diseases Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2021 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 Regional Market Share and Leading Players, 2021
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 SWOT Analysis
8.6.1 North America
8.6.2 Europe
8.6.3 Asia Pacific
8.6.4 Latin America
8.6.5 Middle East and Africa
8.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
8.7.1 North America
8.7.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.7.1.2 U.S.
8.7.1.2.1 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.1.3 Canada
8.7.1.3.1 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2 Europe
8.7.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2.2 U.K.
8.7.2.2.1 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2.3 Germany
8.7.2.3.1 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2.4 Spain
8.7.2.4.1 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2.5 France
8.7.2.5.1 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.2.6 Italy
8.7.2.6.1 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3 Asia Pacific
8.7.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
8.7.3.2 Japan
8.7.3.2.1 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3.3 China
8.7.3.3.1 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3.4 India
8.7.3.4.1 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3.5 South Korea
8.7.3.5.1 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.3.6 Australia
8.7.3.6.1 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.4 Latin America
8.7.4.1 Latin America market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
8.7.4.2 Brazil
8.7.4.2.1 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.4.3 Mexico
8.7.4.3.1 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.4.4 Argentina
8.7.4.4.1 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.5 MEA
8.7.5.1 MEA market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
8.7.5.2 South Africa
8.7.5.2.1 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.5.3 Saudi Arabia
8.7.5.3.1 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
8.7.5.4 UAE
8.7.5.4.1 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.3.3 Key company market share analysis, 2021
9.4 Public Companies
9.4.1 Company market position analysis
9.4.2 Company market share, by region, 2021
9.4.3 Competitive dashboard analysis
9.4.3.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 BD
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic initiatives
9.6.2 bioMérieux SA
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Abbott
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 Quidel Corporation
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 OraSure Technologies, Inc
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic initiatives
9.6.6 Hologic Inc. (Gen-Probe)
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic initiatives
9.6.7 Cepheid (Danaher)
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 QIAGEN
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 F. Hoffmann-La Roche Ltd.
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Siemens Healthcare GmbH
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Bio-Rad Laboratories, Inc.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives

List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Million)
TABLE 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
TABLE 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
TABLE 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 47 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
TABLE 48 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 49 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 50 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 51 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 52 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 53 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 54 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 55 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 56 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 57 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 58 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 59 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 60 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 61 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 62 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 63 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 64 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 65 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 66 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 67 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 68 Singapore IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 69 Singapore IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 70 Singapore IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 71 Singapore IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 72 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 73 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 74 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 75 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 76 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
TABLE 77 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 78 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 79 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 80 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 81 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 82 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 83 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 84 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 85 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 86 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 87 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 88 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 89 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 90 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 91 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 92 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 93 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
TABLE 94 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 95 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 96 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 97 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 98 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 99 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 100 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 101 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 102 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 103 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 104 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 105 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
TABLE 106 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
TABLE 107 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
TABLE 108 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
TABLE 109 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures
FIG. 1 IVD infectious diseases market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Primary interviews in North America
FIG. 6 Primary interviews in Europe
FIG. 7 Primary interviews in Asia Pacific
FIG. 8 Primary interviews in Middle East and Africa
FIG. 9 Market research approaches
FIG. 10 Value-chain-based sizing & forecasting
FIG. 11 QFD modeling for market share assessment
FIG. 12 Market formulation & validation
FIG. 13 IVD infectious disease market snapshot
FIG. 14 Segment Insights
FIG. 15 Strategy framework
FIG. 16 Penetration & growth prospect mapping
FIG. 17 Consumer behavior analysis
FIG. 18 Factors influencing North America IVD infectious diseases market (%)
FIG. 19 Factors influencing Europe IVD infectious diseases market (%)
FIG. 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
FIG. 21 Factors influencing Latin America IVD infectious diseases market (%)
FIG. 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
FIG. 23 Market driver relevance analysis (Current & future impact)
FIG. 24 Global population growth, by age group, 2012 - 2021 (Million)
FIG. 25 Global percentage of the population, by age group, 2000 and 2050
FIG. 26 General trend of CLIA-waived tests
FIG. 27 Market restraint relevance analysis (Current & future impact)
FIG. 28 Porter’s five forces analysis
FIG. 29 PESTLE analysis
FIG. 30 Strategy mapping
FIG. 31 IVD infectious diseases market: Product movement analysis
FIG. 32 Product segment dashboard
FIG. 33 IVD infectious diseases market product outlook: Key takeaways
FIG. 34 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 35 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 36 Software market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 37 IVD infectious diseases market: Technology movement analysis
FIG. 38 Technology segment dashboard
FIG. 39 IVD infectious diseases market technology outlook: Key takeaways
FIG. 40 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 43 In Situ Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 45 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 47 Transcription Mediated Amplification market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 51 IVD infectious diseases market: Technology movement analysis
FIG. 52 Application segment dashboard
FIG. 53 IVD infectious diseases market technology outlook: Key takeaways
FIG. 54 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 55 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 57 VRE market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 58 CRE market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 59 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 60 Candida market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 61 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 62 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 63 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 64 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 65 HPV market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 66 HIV market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 67 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 68 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 69 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 71 IVD infectious diseases market: Test location movement analysis
FIG. 72 Test location segment dashboard
FIG. 73 IVD infectious diseases market test location outlook: Key takeaways
FIG. 74 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 75 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 77 Regional outlook, 2021 & 2030
FIG. 78 Regional market dashboard
FIG. 79 Regional marketplace: Key takeaways
FIG. 80 North America market share and leading players, 2021
FIG. 81 Europe market share and leading players, 2021
FIG. 82 Asia Pacific market share and leading players, 2021
FIG. 83 Latin America market share and leading players, 2021
FIG. 84 Middle East and Africa market share and leading players, 2021
FIG. 85 North America, SWOT
FIG. 86 Europe, SWOT
FIG. 87 Asia Pacific, SWOT
FIG. 88 Latin America, SWOT
FIG. 89 Middle East and Africa, SWOT
FIG. 90 North America
FIG. 91 North America IVD infectious diseases market, 2018 - 2030 (USD Million)
FIG. 92 U.S.
FIG. 93 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 94 Canada
FIG. 95 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 96 Europe
FIG. 97 Europe IVD infectious diseases market, 2018 - 2030 (USD Million)
FIG. 98 U.K.
FIG. 99 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 100 Germany
FIG. 101 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 102 Spain
FIG. 103 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 104 France
FIG. 105 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 106 Italy
FIG. 107 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 108 Asia Pacific
FIG. 109 Asia Pacific IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 110 Japan
FIG. 111 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 112 China
FIG. 113 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 114 India
FIG. 115 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 116 South Korea
FIG. 117 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 118 Australia
FIG. 119 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 120 Latin America
FIG. 121 Latin America IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 122 Brazil
FIG. 123 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 124 Mexico
FIG. 125 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 126 Argentina
FIG. 127 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 128 MEA
FIG. 129 MEA IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 130 South Africa
FIG. 131 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 132 Saudi Arabia
FIG. 133 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 134 UAE
FIG. 135 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 136 Ansoff Matrix
FIG. 137 Heat map analysis
FIG. 138 Company market share analysis
FIG. 139 Company market position analysis
FIG. 140 Company market share, by region, 2021
FIG. 141 Market differentiators